The global organs-on-chips market size is expected to reach USD 294.75 million by 2028 at a CAGR of 36.5% according to the latest report by Reports and Data. The market revenue growth is driven by various factors including increasing requirement for alternatives for animal testing and rising need for early detection of drug toxicity.
An organ-on-a-chip is a microfluidic cell culture device containing continuously perfused chambers. This chip develops a thin and narrow channel, passaging the blood and airflow in several organs, such as heart, lung, liver, and gut. Moreover, these devices are able to produce multiple levels of tissue and organ functionalities, which are not feasible using conventional 3D and 2D culture systems. Therefore, organs-on-chips offer a broad array of applications including patient stratification, disease modeling, and phenotypic screening, which in turn are promoting the revenue growth of the market.
Various advantages of organs-on-chips over cell culture, animal models, and human clinical trials have captured the attention of pharmaceutical and medical communities concentrating on developing various targeted therapies. It is being explored globally as the most effective tool for developing different disease models along with accurately predicting drug efficacies as well as toxicities. Additionally, rising adoption from numerous companies and universities that have been seeking advanced models for drug development is augmenting demand for organs-on-chips devices, thus, accelerating the revenue growth of the market.
Furthermore, increasing demand for personalized medication and the huge applications of organs-on-chips other than pharmaceutical industry are crucial factors creatinggrowth opportunities for market players. However, rising complexity of organ-on-chip models is predicted to hinder the market revenue growth to a certain extent.
Further key findings in the report
- In October 2020, BioVox raised awareness regarding promotion of organ-on-chip technology to improvise on in vitro research models and reduce animal testing.
- The lung-on-chip technology is extremely complex. It is made up of human lung and blood vessel cells, and is able to predict the absorption of airborne nanoparticles and mimic the inflammatory response triggered by different types of microbial pathogens.
- Organs-on-chips devices can also be utilized for testing effects of environmental toxins, efficacy and safety of new drugs, and absorption of aerosolized therapeutics. Due to such advantages, these devices are expected to become a suitable alternative for animal testing.
- North American market is predicted to register highest revenue share in the global market going ahead owing to various factors including the availability of a wide range of services offered by prominent players in the region and rising toxicological testing of chemicals on different types of organ cells.
Key Players covered in this report are
Emulate (U.S.), Mimetas (Netherlands), InSphero (Switzerland), CN Bio (UK), AxoSim (U.S.), Ascendance Bio (U.S.), TissUse (Germany), HUREL (HUREL) (U.S.), Kirkstall (UK), SynVivo (U.S.), and Nortis (U.S.).
Type Outlook (Revenue, USD Million, 2018 - 2028)
- Liver
- Kidney
- Lung
- Heart
- Intestines
- Other organ types
Offering Outlook (Revenue, USD Million, 2018 - 2028)
- Product
- Service
Application Outlook (Revenue, USD Million, 2018 - 2028)
- Drug discovery
- Toxicology research
- Physiological Model
- Other applications
End User Outlook (Revenue, USD Million, 2018 – 2028)
- Pharmaceutical and biotechnology companies
- Academic
- Research institutes
Based on Region market is segmented into:
- North America
- Europe
- Asia-Pacific
- South America
- Middle East Africa
Request a sample Report of Organs-on-Chips Market @ https://www.reportsanddata.com/sample-enquiry-form/4034
Major Points covered in this report are as below:
• The Organs-on-Chips industry development trends and marketing channels are analyzed. The feasibility of new investment projects are assessed and overall research conclusions offered.
• With the tables and figures, the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
• Development policies and plans, manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand figures, cost, price, revenue and gross margins.
• The Organs-on-Chips Market report provides key statistics on the market status of the Organs-on-Chips manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.
We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central South America, Brazil, Argentina, Rest of South America, Middle East Africa, Saudi Arabia, Turkey, Rest of Middle East Africa
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
